COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
11/07/2024
First Licensing Agreement for coactiv+™ Scalp Care Line WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a [...]
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
10/07/2024
CHATHAM, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced the closing of its public [...]
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
10/07/2024
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene Medicine Corporation (the [...]
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
10/07/2024
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule [...]
Desert Hope Treatment Center Promotes Kristin Berg to Executive Director, Solidifying its Position as a Market Leader
10/07/2024
LAS VEGAS, July 10, 2024 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment provider in Las Vegas, is proud to announce the promotion of Kristin Berg to the position of Executive Director. [...]
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
10/07/2024
PRESS RELEASE REGULATED INFORMATION 10 July 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 10 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA [...]
GrayHawk Health Leverages Innovaccer’s Technology to Transform In-Home Healthcare for At Risk Populations
10/07/2024
PA-based GrayHawk Health will use Innovaccer’s Population Health Analytics and Data Platform to accelerate development of its healthcare experience platform (HXP) , validate quality and to improve in-home care delivery [...]
Elite MedSpa, Ivy En Rose, Unveils Groundbreaking Longevity Program and Announces Upcoming Launch of Membership Rewards
10/07/2024
SAN FRANCISCO, July 10, 2024 (GLOBE NEWSWIRE) -- Ivy En Rose , an elite medspa in San Francisco, is thrilled to announce the launch of their innovative Longevity Program, designed to help clients achieve and maintain [...]
FSH-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomized clinical trial
10/07/2024
AMSTERDAM, July 10, 2024 (GLOBE NEWSWIRE) -- This randomized, controlled trial was conducted at a tertiary IVF center, Ho Chi Minh City, Vietnam. Between January 2023 and June 2023, 120 women were randomized. Eligible [...]
Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
10/07/2024
The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; [...]
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/07/2024
DENVER, July 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 947, [...]
Two USOSM Partner Practices Receive AAAHC Accreditation
10/07/2024
Recognition Enables Oral and Maxillofacial Surgery Centers of Excellence Distinction IRVING, Texas, July 10, 2024 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited two [...]
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10/07/2024
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, [...]
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
10/07/2024
Skyhawk’s SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in the multiple ascending dose study SKY-0515 was generally well [...]
Creative Medical Technology Holdings Provides Corporate Update
10/07/2024
PHOENIX, July 10, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ) , a biotechnology company focused on a regenerative approach to [...]
Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida
10/07/2024
Reports progress in reimbursement strategy with additional JMAC regions ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery [...]
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
10/07/2024
Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applications Tevogen’s ExacTcell™ platform is designed to address current cost, and patient accessibility challenges ExacTcell’s first [...]
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
10/07/2024
RECCE ® 327 (R327) demonstrated significant bactericidal activity against ‘superbug’ Acinetobacter baumannii ( A. baumannii ) demonstrating 99.99999% log reduction (>7.5 log reduction) in adult human epidermal ‘skin [...]
Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
10/07/2024
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9 [...]

Pages